SCHEMBL21585664

SCHEMBL21585664

C=C(C(=O)NN)c1cnccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ MC4R P32245 1/20 0.53
▸ ADRA1A P35348 1/20 0.53
▸ MC3R P41968 1/20 0.53
▸ KDM4E B2RXH2 5/20 0.50
▸ NAPRT Q6XQN6 1/20 0.50
▸ HCAR2 Q8TDS4 1/20 0.50
▸ BAZ2B Q9UIF8 1/20 0.44
▸ HDAC3 O15379 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ NPC1 O15118 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ MCL1 Q07820 1/20 0.40
▸ KMT2A Q03164 2/20 0.39
▸ PABPC1 P11940 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrazine Carboxylic Acid Hydrazide SCHEMBL107341 0.77 ADORA3 (0.61) ADORA3TSHRMC4RADRA1AMC3R
SCHEMBL8336840 0.77 KDM4E (0.63) ADORA3TSHRMC4RADRA1AMC3R
Pyrazine Carboxylic Acid Hydrazide SCHEMBL18038330 0.76 ADORA3 (0.59) ADORA3TSHRMC4RADRA1AMC3R
SCHEMBL21585663 0.75 CES2 (0.52) KDM4ENAPRTHDAC3HDAC1HDAC2
Hydrochloric Acid SCHEMBL27752878 0.74 KDM4E (0.48) ADORA3TSHRMC4RADRA1AMC3R
SCHEMBL27791569 0.72 KDM4E (0.55) ADORA3TSHRMC4RADRA1AMC3R
SCHEMBL5796700 0.71 KDM4E (0.50) ADORA3TSHRMC4RADRA1AMC3R
SCHEMBL4904135 0.71 BAZ2B (0.52) ADORA3TSHRMC4RADRA1AMC3R
Pyrazinamide SCHEMBL18364989 0.70 — —
Pyrazinamide SCHEMBL24102 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4178563-A1 TYROSINE, TRYPTOPHAN AND PHENYLALANINE AS MTOR AGONISTS MEDIATING PROTEASOME DYNAMICS, COMPOSITIONS, METHODS AND USES THEREOF IN THERAPY, AND PROGNOSTIC METHODS FOR DRUG-RESISTANCE Technion Research & Development Foundation Ltd. (IL) 2023-05-17 — — EP disclosed
EP-3802501-A1 COMPOUNDS AS NUCLEAR TRANSPORT MODULATORS AND USES THEREOF XW Laboratories Inc. (KY) 2021-04-14 — — EP disclosed
WO-2019233447-A1 COMPOUNDS AS NUCLEAR TRANSPORT MODULATORS AND USES THEREOF XW LABORATORIES, INC. (CN) 2019-12-12 — — WO disclosed
Send feedback